Petra Schurr
MD
Medical Oncologist
👥Biography 个人简介
Petra Schurr has contributed to triple-negative breast cancer (TNBC) clinical research in Germany, including trials of neoadjuvant chemotherapy and immunotherapy in TNBC. The KEYNOTE-522 trial establishing pembrolizumab plus neoadjuvant chemotherapy followed by adjuvant pembrolizumab for early TNBC represented a major practice change in TNBC management.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Petra Schurr 的研究动态
Follow Petra Schurr's research updates
留下邮箱，当我们发布与 Petra Schurr（University Hospital Hamburg-Eppendorf）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment